Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of PERINDOPRES® DUO vs Noliterax® in Healthy Subjects
NCT05464745Phase 1Completed
- Sponsor
- Darnitsa
- Start
- May 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of perindopril tert-butylamine and indapamide in hypertension (HTN) and heart failure (HF) (2 arms), sponsored by Darnitsa. Primary endpoints: Maximum Plasma Concentration of Perindopril, Area Under the Concentration-Time Curve of Perindopril and 2 more. Started May 2021; status: completed.
02
Drugs
perindopril tert-butylamineindapamide
03
Conditions
hypertension (HTN)heart failure (HF)
Beyond the preview
Go deeper on NCT05464745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05464745.